ClinicalTrials.govpublic full text
A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
multiple myeloma, velcade, doxil, melphalan, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 874585
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.